A detailed history of Operose Advisors LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Operose Advisors LLC holds 205 shares of BSX stock, worth $17,379. This represents 0.01% of its overall portfolio holdings.

Number of Shares
205
Previous 205 -0.0%
Holding current value
$17,379
Previous $14,000 7.14%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$48.64 - $57.81 $41,587 - $49,427
-855 Reduced 80.66%
205 $11,000
Q3 2023

Nov 13, 2023

BUY
$50.19 - $54.68 $53,201 - $57,960
1,060 New
1,060 $55,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $121B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Operose Advisors LLC Portfolio

Follow Operose Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Operose Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Operose Advisors LLC with notifications on news.